Hsbc Holdings PLC Alkermes Plc. Transaction History

Hsbc Holdings PLC

  • $176 Billion
  • Q3 2025

A detailed history of Hsbc Holdings PLC transactions in Alkermes Plc. stock. As of the latest transaction made, Hsbc Holdings PLC holds 35,548 shares of ALKS stock, worth $1.03 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
35,548
Previous 110,816 67.92%
Holding current value
$1.03 Million
Previous $3.17 Million 66.37%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025
SELL
$26.13 - $30.46 $1.97 Million - $2.29 Million
-75,268 Reduced 67.92%
35,548 $1.07 Million
Q2 2025

Aug 13, 2025
BUY
$26.59 - $32.65 $791,318 - $971,664
29,760 Added 36.72%
110,816 $3.17 Million
Q1 2025

May 14, 2025
BUY
$28.08 - $36.0 $1.44 Million - $1.85 Million
51,393 Added 173.26%
81,056 $2.68 Million
Q4 2024

Feb 14, 2025
BUY
$25.7 - $31.46 $424,923 - $520,159
16,534 Added 125.93%
29,663 $853,000
Q3 2024

Nov 14, 2024
BUY
$23.01 - $28.55 $302,098 - $374,832
13,129 New
13,129 $367,000
Q1 2024

May 15, 2024
BUY
$26.4 - $32.56 $1.23 Million - $1.52 Million
46,644 Added 167.37%
74,512 $2.02 Million
Q4 2023

Feb 12, 2024
SELL
$23.37 - $28.68 $1.5 Million - $1.84 Million
-64,103 Reduced 69.7%
27,868 $773,000
Q3 2023

Nov 13, 2023
BUY
$27.17 - $31.97 $1.47 Million - $1.73 Million
54,231 Added 143.7%
91,971 $2.58 Million
Q2 2023

Aug 11, 2023
BUY
$28.34 - $33.63 $472,371 - $560,544
16,668 Added 79.1%
37,740 $1.18 Million
Q1 2023

May 15, 2023
BUY
$25.31 - $29.02 $187,344 - $214,806
7,402 Added 54.15%
21,072 $594,000
Q4 2022

Feb 14, 2023
BUY
$21.94 - $26.24 $299,919 - $358,700
13,670 New
13,670 $357,000
Q2 2022

Aug 11, 2022
SELL
$26.4 - $30.54 $841,816 - $973,828
-31,887 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$23.07 - $27.99 $186,267 - $225,991
8,074 Added 33.91%
31,887 $853,000
Q4 2021

Feb 11, 2022
BUY
$21.47 - $32.08 $76,776 - $114,718
3,576 Added 17.67%
23,813 $553,000
Q3 2021

Nov 12, 2021
SELL
$23.37 - $32.13 $196,097 - $269,602
-8,391 Reduced 29.31%
20,237 $627,000
Q2 2021

Aug 13, 2021
SELL
$18.78 - $25.15 $150,108 - $201,023
-7,993 Reduced 21.83%
28,628 $701,000
Q1 2021

May 14, 2021
SELL
$18.21 - $23.2 $84,275 - $107,369
-4,628 Reduced 11.22%
36,621 $684,000
Q4 2020

Feb 12, 2021
SELL
$15.39 - $22.1 $18,329 - $26,321
-1,191 Reduced 2.81%
41,249 $822,000
Q3 2020

Nov 12, 2020
BUY
$16.16 - $20.66 $15,028 - $19,213
930 Added 2.24%
42,440 $704,000
Q2 2020

Aug 14, 2020
BUY
$13.31 - $19.41 $552,498 - $805,709
41,510 New
41,510 $806,000
Q1 2020

May 15, 2020
SELL
$13.06 - $21.24 $327,988 - $533,421
-25,114 Closed
0 $0
Q4 2019

Feb 14, 2020
SELL
$17.29 - $21.74 $925,239 - $1.16 Million
-53,513 Reduced 68.06%
25,114 $513,000
Q3 2019

Nov 14, 2019
SELL
$19.51 - $24.28 $698,067 - $868,738
-35,780 Reduced 31.27%
78,627 $1.53 Million
Q2 2019

Aug 13, 2019
BUY
$21.47 - $37.33 $2.46 Million - $4.27 Million
114,407 New
114,407 $2.58 Million
Q4 2018

Feb 13, 2019
SELL
$27.94 - $44.61 $154,228 - $246,247
-5,520 Closed
0 $0
Q3 2018

Nov 13, 2018
BUY
$38.6 - $46.12 $213,072 - $254,582
5,520 New
5,520 $235,000
Q1 2018

May 11, 2018
SELL
$53.61 - $67.26 $867,463 - $1.09 Million
-16,181 Closed
0 $0
Q4 2017

Feb 14, 2018
BUY
$47.69 - $55.39 $110,831 - $128,726
2,324 Added 16.77%
16,181 $885,000
Q3 2017

Nov 14, 2017
BUY
$49.16 - $54.45 $681,210 - $754,513
13,857
13,857 $704,000

Others Institutions Holding ALKS

# of Institutions
401
Shares Held
176M
Call Options Held
901K
Put Options Held
400K
View Full List

About Alkermes plc.

ALKS Quotes by TradingView
  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.77B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Hsbc Holdings PLC Portfolio

Follow Hsbc Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email